Showing results (1111-1120 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|July 1, 1996
Use of targeted cationic liposomes in enhanced DNA delivery to cancer cellsG Y Kao, L J Change, T M AllenCancer Gene Therapy|September 1, 1996
Murine neuroblastoma vaccines produced by retroviral transfer of MHC class II genesR A Hock, B D Reynolds, C L Tucker-McClung, et al.Cancer Gene Therapy|December 25, 2007
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapyK A Bickenbach, J Veerapong, M Y Shao, et al.Cancer Gene Therapy|December 25, 2007
Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecanJ Uchino, K Takayama, A Harada, et al.Cancer Gene Therapy|January 23, 1999
Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 geneY Gunji, K Tasaki, M Tagawa, et al.Cancer Gene Therapy|January 23, 1999
Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancerT D Chung, H J Mauceri, D E Hallahan, et al.Cancer Gene Therapy|January 23, 1999
Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cellsS Salesse, F Moreau-Gaudry, V Pigeonnier-Lagarde, et al.Cancer Gene Therapy|September 1, 1995
Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNAD W Cai, T Mukhopadhyay, J A RothCancer Gene Therapy|September 1, 1995
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCLM R Smith, Y Abubakr, R Mohammad, et al.Cancer Gene Therapy|March 1, 1996
Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect"S Gagandeep, R Brew, B Green, et al.Pageof 292